Bioinformatics Market Is Expected To Witness Revenue Growth To $12.48 Billion by 2020: Grand View Research, Inc.

The global market for bioinformatics is expected to reach USD 12.48 billion by 2020, according to a new study by Grand View Research, Inc. Rapidly declining prices of DNA sequencing, growing adoption rates of bioinformatics as a cost effective tool for database management during clinical trials, increasing government initiatives encouraging the use of bioinformatics in drug discovery and the use of bioinformatics tools in emerging fields such as chemogenomics are some of the factors expected to drive market growth over the next six years. In addition, the introduction of advance technologies such as nanopore and cloud computing are expected to serve this market as future growth opportunities.

Bioinformatics platform products are expected to dominate the market, along with being the fastest growing segment, at an estimated CAGR of 22.8% from 2014 to 2020. The increasing demand for these platforms in technologically advanced processes such as high throughput screening for combination therapies namely pharmacogenomics and pharmacoproteomics is expected to serve this market as drivers during the forecast period. Global biocontent product demand is expected to reach USD 4.30 billion by 2020, growing at a CAGR of 16.9% from 2014 to 2020.

To request a sample copy or view summary of this report, click the link below:

http://www.grandviewresearch.com/industry-analysis/bioinformatics-industry

For more information, visit http://www.grandviewresearch.com/